Abstract
In recent years, there has been a considerable amount of interest in the area of Genomic Signal Processing, which is the engineering discipline that studies the processing of genomic signals. Since regulatory decisions within the cell utilize numerous inputs, analytical tools are necessary to model the multivariate influences on decision-making produced by complex genetic networks. Signal processing approaches such as detection, prediction and classification have been used in the recent past to construct genetic regulatory networks capable of modeling genetic behavior. To accommodate the large amount of uncertainty associated with this kind of modeling, many of the networks proposed are probabilistic. One of the objectives of network modeling is to use the network to design different intervention approaches for affecting the time evolution of the gene activity profile of the network. More specifically, one is interested in intervening to help the network avoid undesirable states such as those associated with a disease. This paper provides a tutorial survey of the intervention approaches developed so far in the literature for probabilistic gene networks (probabilistic Boolean networks) and outlines some of the open challenges that remain.
Keywords: Gene regulatory network, markov chain, steady-state distribution, optimal control, dynamic programming, context sensitive networks
Current Bioinformatics
Title: Intervention in Probabilistic Gene Regulatory Networks
Volume: 1 Issue: 2
Author(s): Aniruddha Datta, Ranadip Pal and Edward R. Dougherty
Affiliation:
Keywords: Gene regulatory network, markov chain, steady-state distribution, optimal control, dynamic programming, context sensitive networks
Abstract: In recent years, there has been a considerable amount of interest in the area of Genomic Signal Processing, which is the engineering discipline that studies the processing of genomic signals. Since regulatory decisions within the cell utilize numerous inputs, analytical tools are necessary to model the multivariate influences on decision-making produced by complex genetic networks. Signal processing approaches such as detection, prediction and classification have been used in the recent past to construct genetic regulatory networks capable of modeling genetic behavior. To accommodate the large amount of uncertainty associated with this kind of modeling, many of the networks proposed are probabilistic. One of the objectives of network modeling is to use the network to design different intervention approaches for affecting the time evolution of the gene activity profile of the network. More specifically, one is interested in intervening to help the network avoid undesirable states such as those associated with a disease. This paper provides a tutorial survey of the intervention approaches developed so far in the literature for probabilistic gene networks (probabilistic Boolean networks) and outlines some of the open challenges that remain.
Export Options
About this article
Cite this article as:
Datta Aniruddha, Pal Ranadip and Dougherty R. Edward, Intervention in Probabilistic Gene Regulatory Networks, Current Bioinformatics 2006; 1 (2) . https://dx.doi.org/10.2174/157489306777011978
DOI https://dx.doi.org/10.2174/157489306777011978 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanoparticulate Drug Delivery System to Overcome the Limitations of Conventional Curcumin in the Treatment of Various Cancers: A Review
Drug Delivery Letters Review of Procedures Used for the Extraction of Anti-Cancer Compounds from Tropical Plants
Anti-Cancer Agents in Medicinal Chemistry DNA Double Strand Break Repair - Related Synthetic Lethality
Current Medicinal Chemistry Fluorescent Porphyrin with an Increased Uptake in Peripheral Blood Cell Subpopulations from Colon Cancer Patients
Medicinal Chemistry Thiol Proteases: Inhibitors and Potential Therapeutic Targets
Current Medicinal Chemistry Synthesis and Antiproliferative Activity of 2-arylidene 6-(2-aryl-2-oxoethoxy)Benzofuran-3-one Derivatives
Letters in Drug Design & Discovery Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein
Current Medicinal Chemistry An Overview of Piperazine Scaffold as Promising Nucleus for Different Therapeutic Targets
Current Pharmaceutical Design Editorial: Bioactive Fungal Metabolites
Current Medicinal Chemistry Patent Selections
Recent Patents on Biomarkers Synthesis and Molecular Simulation Studies of Mandelic Acid Peptidomimetic Derivatives as Aminopeptidase N Inhibitors
Current Computer-Aided Drug Design Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract
Current Pharmaceutical Design Role of Nitric Oxide in the Modulation of Angiogenesis
Current Pharmaceutical Design Developments in Selective Small Molecule ATP-Targeting the Serine/Threonine Kinase Akt/PKB
Mini-Reviews in Medicinal Chemistry The State-of-Art in Angiogenic Properties of Latex from Different Plant Species
Current Angiogenesis (Discontinued) Nanoconstructs in Targeted Alpha-Therapy
Recent Patents on Nanomedicine Experimental Therapy for Lung Cancer: Umbilical Cord-Derived Mesenchymal Stem Cell-Mediated Interleukin-24 Delivery
Current Cancer Drug Targets Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers
Anti-Cancer Agents in Medicinal Chemistry Enhancing the Site-Specific Targeting of Macromolecular Anticancer Drug Delivery Systems
Current Drug Targets Virus, Oncolytic Virus and Human Prostate Cancer
Current Cancer Drug Targets